Plethora Solutions Holdings Plc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Plethora Solutions Holdings Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0500
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Plethora Solutions Holdings plc (Plethora), a subsidiary of Regent Pacific is a pharmaceutical company which develops and markets products for the treatment and management of urological disorders. It focuses on the development of medicines for the treatment of urology and sexual health. The company’s lead product candidate is Fortacin, a metered-dose aerosol formulation of lidocaine and prilocaine. It is topical product for the treatment of premature ejaculation. The product has received marketing approval in Europe. The company has partnerships with companies such as Recordati and Pharmaserve among others. Plethora is headquartered in Chalgrove, Oxfordshire, the UK.

Plethora Solutions Holdings Plc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Recordati and Plethora Enter into Co-Development Agreement with Pharmaserve for PSD502 10
Licensing Agreements 11
Recordati Amends Licensing Agreement with Plethora Solutions for Fortacin 11
Plethora Plans to Enter into Licensing Agreement for Fortacin 13
Plethora Enters into Licensing Agreement with Recordati for PSD502 14
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 16
Equity Offering 18
Plethora to Raise USD3.8 Million in Private Placement of Shares and Warrants 18
Plethora Solutions Announces Private Placement Of Shares For Us$7 Million 20
Plethora Solutions Completes Private Placement Of Shares For US$3 Million 21
Plethora Solutions Completes Private Placement Of Shares For US$0.5 Million 22
Acquisition 23
Regent Pacific Acquires Remaining 70.12% Stake in Plethora Solutions 23
Plethora Solutions Holdings Plc – Key Competitors 25
Plethora Solutions Holdings Plc – Key Employees 26
Plethora Solutions Holdings Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Key Facts 2
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plethora Solutions Holdings Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recordati and Plethora Enter into Co-Development Agreement with Pharmaserve for PSD502 10
Recordati Amends Licensing Agreement with Plethora Solutions for Fortacin 11
Plethora Plans to Enter into Licensing Agreement for Fortacin 13
Plethora Enters into Licensing Agreement with Recordati for PSD502 14
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 16
Plethora to Raise USD3.8 Million in Private Placement of Shares and Warrants 18
Plethora Solutions Announces Private Placement Of Shares For Us$7 Million 20
Plethora Solutions Completes Private Placement Of Shares For US$3 Million 21
Plethora Solutions Completes Private Placement Of Shares For US$0.5 Million 22
Regent Pacific Acquires Remaining 70.12% Stake in Plethora Solutions 23
Plethora Solutions Holdings Plc, Key Competitors 25
Plethora Solutions Holdings Plc, Key Employees 26
Plethora Solutions Holdings Plc, Subsidiaries 27

List of Figures
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Plethora Solutions Holdings Plc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heineken NV:企業のM&A・事業提携・投資動向
    Heineken NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heineken NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Neptune Technologies & Bioressources Inc:企業のM&A・事業提携・投資動向
    Neptune Technologies & Bioressources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neptune Technologies & Bioressources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aditya Birla Sun Life Insurance Company Limited:企業の戦略・SWOT・財務分析
    Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DSK Bank EAD :企業の戦略・SWOT・財務情報
    DSK Bank EAD - Strategy, SWOT and Corporate Finance Report Summary DSK Bank EAD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Genetic Analysis AS:製品パイプライン分析
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Shelby Energy Cooperative, Inc.:企業の戦略的SWOT分析
    Shelby Energy Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bank of Singapore Ltd.:企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Belfius Bank Sa:企業の戦略・SWOT・財務分析
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Citius Pharmaceuticals Inc (CTXR):製薬・医療:M&Aディール及び事業提携情報
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • OKD as:企業の戦略・SWOT・財務情報
    OKD as - Strategy, SWOT and Corporate Finance Report Summary OKD as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆